Viemed Healthcare Inc
TSX:VMD
Balance Sheet
Balance Sheet Decomposition
Viemed Healthcare Inc
Viemed Healthcare Inc
Balance Sheet
Viemed Healthcare Inc
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
4
|
5
|
10
|
13
|
31
|
29
|
17
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
12
|
6
|
|
| Cash Equivalents |
4
|
5
|
10
|
13
|
31
|
17
|
11
|
|
| Total Receivables |
5
|
10
|
9
|
12
|
12
|
15
|
15
|
|
| Accounts Receivables |
5
|
10
|
9
|
12
|
12
|
13
|
15
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
2
|
0
|
|
| Inventory |
2
|
2
|
3
|
1
|
2
|
3
|
4
|
|
| Other Current Assets |
0
|
1
|
1
|
2
|
2
|
2
|
4
|
|
| Total Current Assets |
11
|
17
|
23
|
28
|
47
|
47
|
40
|
|
| PP&E Net |
14
|
21
|
31
|
55
|
55
|
63
|
68
|
|
| PP&E Gross |
14
|
21
|
31
|
55
|
55
|
63
|
68
|
|
| Accumulated Depreciation |
4
|
6
|
9
|
14
|
20
|
28
|
40
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
1
|
2
|
4
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
10
|
6
|
5
|
|
| Total Assets |
25
N/A
|
38
+53%
|
54
+42%
|
83
+54%
|
113
+36%
|
118
+5%
|
117
-1%
|
|
| Liabilities | ||||||||
| Accounts Payable |
4
|
3
|
6
|
5
|
3
|
5
|
5
|
|
| Accrued Liabilities |
1
|
5
|
8
|
9
|
11
|
7
|
9
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
4
|
4
|
3
|
9
|
5
|
2
|
1
|
|
| Other Current Liabilities |
0
|
0
|
3
|
3
|
4
|
4
|
5
|
|
| Total Current Liabilities |
9
|
13
|
20
|
26
|
23
|
18
|
19
|
|
| Long-Term Debt |
3
|
1
|
0
|
11
|
7
|
5
|
0
|
|
| Other Liabilities |
0
|
0
|
1
|
2
|
1
|
1
|
1
|
|
| Total Liabilities |
12
N/A
|
14
+18%
|
21
+52%
|
39
+84%
|
31
-21%
|
23
-25%
|
20
-14%
|
|
| Equity | ||||||||
| Common Stock |
0
|
0
|
0
|
3
|
9
|
14
|
15
|
|
| Retained Earnings |
13
|
21
|
27
|
34
|
66
|
73
|
70
|
|
| Additional Paid In Capital |
0
|
3
|
5
|
6
|
7
|
8
|
12
|
|
| Other Equity |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Total Equity |
13
N/A
|
24
+84%
|
33
+38%
|
44
+34%
|
82
+87%
|
95
+16%
|
97
+2%
|
|
| Total Liabilities & Equity |
25
N/A
|
38
+53%
|
54
+42%
|
83
+54%
|
113
+36%
|
118
+5%
|
117
-1%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
38
|
38
|
38
|
38
|
39
|
40
|
38
|
|